If you work in oncology medical billing, you already know that staying on top of specific codes for new therapies is a daily challenge. Enhertu (fam-trastuzumab deruxtecan-nxki) is a powerful antibody-drug conjugate used to treat certain types of breast cancer, gastric cancer, and non-small cell lung cancer.
But what happens when it is time to submit the claim? You need the exact procedure code.
Let us be honest. Mixing up a single digit can lead to denied claims, delayed payments, and frustrated patients. This guide walks you through everything you need to know about the Enhertu CPT code, from the primary administration code to billing nuances and payer considerations.
We are not here to overwhelm you with medical jargon. Instead, consider this your friendly, reliable roadmap for getting your claims right the first time.
What Is Enhertu? A Quick Overview for Billers
Before we jump into the codes, it helps to understand what makes Enhertu different. This medication is given intravenously. It targets HER2-positive cancer cells and delivers chemotherapy directly inside those cells.
Because it is a specialty drug with significant cost and potential side effects, payers watch Enhertu claims very closely. That means your documentation and coding must be flawless.
Enhertu is typically administered once every three weeks. The dosage depends on the patient’s weight and the specific cancer type. But from a coding perspective, the method of administration is what matters most.
The Primary Enhertu CPT Code: 96413
Here is the most important takeaway. The correct CPT code for the first hour of Enhertu intravenous infusion is 96413.
This code falls under the “chemotherapy administration” section of the CPT manual. Even though Enhertu is a targeted therapy, it is classified as a chemotherapeutic agent for billing purposes.
When you report 96413, you are telling the payer that you provided a complex, parenteral infusion of a chemotherapeutic substance for the first hour.
When To Use 96413
- The patient arrives for their scheduled Enhertu infusion.
- You administer the drug intravenously.
- The total infusion time is at least 15 minutes but less than one hour.
If the infusion goes beyond one hour, you do not simply bill 96413 again. You add an add-on code.
Add-On Codes for Extended Infusion Time
Enhertu infusions often take longer than one hour. The drug is given as an IV drip, and the total infusion duration can range from 30 minutes to 90 minutes or more depending on the dose and patient tolerance.
For each additional hour beyond the first, you use +96415.
This is an add-on code. It cannot be billed alone. It must always follow 96413.
Here is a simple example. A patient receives Enhertu, and the total infusion time is 90 minutes (1.5 hours).
- First hour: 96413
- Additional 30 minutes: +96415 (one unit)
If the infusion takes two hours and 15 minutes (135 minutes), you would bill:
- 96413 (first hour)
- +96415 x 2 units (second hour and the first 15 minutes of the third hour)
Important Note on Time Rounding
Most payers follow the “midnight rule” style for infusion time, but more specifically for chemotherapy, you report 96415 for each additional hour. Partial hours beyond the first hour are rounded based on the specific payer guidelines. For Medicare and many commercial plans, any additional 15 to 60 minutes counts as one unit of +96415.
However, if the additional time is less than 15 minutes, you generally do not bill +96415. You simply absorb that short time into the primary code.
| Infusion Duration | CPT Codes to Bill |
|---|---|
| 15 – 60 minutes | 96413 |
| 61 – 120 minutes | 96413, +96415 |
| 121 – 180 minutes | 96413, +96415 x 2 |
| 181 – 240 minutes | 96413, +96415 x 3 |
This table shows the standard billing pattern, but always verify with your specific payer’s medical policy.
The Hydration and Pre-Meds Question
Before giving Enhertu, patients often receive pre-medications. These might include antihistamines, antipyretics, or antiemetics. They help prevent infusion-related reactions.
How do you bill for the time spent on these pre-medications?
This is where many billers get confused. You have two different scenarios.
Scenario A: Separate Pre-Meds Before Enhertu
If the patient receives IV pre-medications in a separate period before the Enhertu infusion begins, you may bill a hydration or non-chemo IV push code. For example, if the nurse administers IV diphenhydramine and ondansetron over 15 minutes, and then they stop the line before starting Enhertu, you could bill 96360 (hydration) or 96365 (therapeutic infusion) depending on the substance.
However, this is becoming less common. Most practices administer pre-meds as a push or short infusion immediately before Enhertu without a break.
Scenario B: Pre-Meds Immediately Followed by Enhertu
When pre-medications are given as a push or infusion and are immediately followed by the Enhertu infusion with no break in clinical time, you typically cannot bill separately for the pre-meds. The entire service is considered a single chemotherapy visit.
In this case, you bill only the Enhertu administration codes (96413 and +96415). The time for pre-meds is included in the total infusion time for the chemotherapy administration.
Pro tip: Check your payer’s policy on “sequential infusion” billing. Many commercial insurers strictly prohibit separate billing for pre-meds when they lead directly into a chemotherapy infusion. Medicare’s NCCI (National Correct Coding Initiative) edits also bundle these services in most cases.
Pushing vs. Infusion: Do You Need 96409 or 96411?
Enhertu is almost always given as an infusion, not as an IV push. A push is a manual injection given over a few minutes. Enhertu’s prescribing information requires a slow drip. The drug is diluted in a bag of 5% dextrose and infused via an IV pump.
Therefore, you will rarely, if ever, use 96409 (IV push, single or initial substance) or 96411 (IV push, each additional substance) for Enhertu.
Stick with 96413 and +96415. This is the correct and compliant path.
HCPCS Code for the Drug Itself: J9359
Do not forget. The CPT code covers the administration (the nurse’s time, the pump, the supplies). The drug itself requires a separate HCPCS code.
For Enhertu, the HCPCS Level II code is J9359.
This code represents the drug fam-trastuzumab deruxtecan-nxki in 1 mg increments. You will bill one unit for every milligram administered.
How To Calculate J9359 Units
Let us say the ordered dose is 100 mg. You would bill J9359 x 100 units.
The standard dosing for Enhertu is:
- For breast cancer: 5.4 mg/kg every three weeks.
- For gastric cancer: 6.4 mg/kg every three weeks.
You must calculate the exact dosage based on the patient’s weight. Then, convert that dose into milligrams and bill the corresponding number of J9359 units.
Example: A patient weighing 70 kg receives Enhertu for breast cancer.
- 5.4 mg x 70 kg = 378 mg total dose.
- Units for J9359: 378.
Your claim will have both:
- CPT code 96413 (administration, first hour)
- HCPCS code J9359 x 378 units (the drug)
A Complete Sample Claim for Enhertu Infusion
Seeing it all together helps. Imagine a 45-year-old patient with HER2-positive breast cancer. Weight: 80 kg. Dose: 5.4 mg/kg. Total dose: 432 mg. Infusion time: 75 minutes.
Here is the claim line by line.
| Code Type | Code | Units | Description |
|---|---|---|---|
| Administration | 96413 | 1 | Chemotherapy infusion, first hour |
| Administration | +96415 | 1 | Additional hour (the extra 15 minutes) |
| Drug HCPCS | J9359 | 432 | Enhertu per 1 mg |
| Diagnosis | Z51.11 | N/A | Encounter for antineoplastic chemotherapy |
The primary diagnosis will be the cancer itself (e.g., C50.912 for malignant neoplasm of unspecified breast). The Z51.11 is a secondary diagnosis that justifies the chemotherapy encounter.
Common Denials and How to Avoid Them
Even experienced coders run into trouble with Enhertu claims. Let us review the most frequent issues and their simple fixes.
Denial: Mismatched Diagnosis
Some payers require a specific ICD-10 code that matches the FDA-approved indication for Enhertu. If you bill for breast cancer but the documentation mentions an off-label use without supporting literature, the claim may deny.
Fix: Always link the correct primary cancer diagnosis to the J9359 line. Double-check that your documentation supports medical necessity.
Denial: Time Errors on 96413
You bill 96413 for the first hour. If your documentation shows an infusion time of 12 minutes, you cannot bill 96413. The minimum time for 96413 is 15 minutes (by most payer policies). Some require at least 16 minutes.
Fix: Document the exact start and stop time of the infusion. Include this in the nurse’s note. Do not guess.
Denial: Missing Modifiers
This is less common for standalone Enhertu, but if you are billing multiple infusions on the same day, you might need modifiers like -59 (distinct procedural service) or -JW (drug was wasted).
For Enhertu, the -JW modifier is very important. If the vial contains more drug than the patient needs and you cannot save it for a later patient, you bill the wasted amount with modifier -JW.
Example: You open a 100 mg vial. The patient receives 78 mg. You waste 22 mg.
- J9359 x 78 (administered)
- J9359 x 22 with modifier -JW (wasted)
Medicare and many commercial plans require this. Without the -JW modifier, they may deny the waste portion.
Site of Service: Hospital Outpatient vs. Private Clinic
Where you give Enhertu changes the coding slightly. Not the codes themselves, but the payment rates and billing rules.
Hospital Outpatient Department (HOPD)
Hospitals bill under the Outpatient Prospective Payment System (OPPS). They use the same CPT and HCPCS codes, but payment is higher for the drug and administration due to facility overhead. Hospitals also report C9794? No. Be careful. C9794 is not for Enhertu. That code is for a different therapy. Stick with J9359.
Hospitals need to report line-level modifiers and possibly the “G” codes for additional clarification depending on the payer.
Private Oncology Clinic (Physician Office)
Private practices bill under the Physician Fee Schedule. The drug acquisition cost for Enhertu is high, and reimbursement comes from the Average Sales Price (ASP) plus 6% under Medicare Part B. You must ensure your practice has enrolled in Medicare’s Part B drug program.
The administration codes (96413, etc.) reimburse at a lower rate than in a hospital, but your overhead is also lower.
| Site of Service | Drug Code | Administration Code | Typical Reimbursement |
|---|---|---|---|
| Hospital Outpatient | J9359 | 96413 (higher facility rate) | ASP + 6% (drug); higher admin |
| Physician Office | J9359 | 96413 (lower non-facility rate) | ASP + 6% (drug); lower admin |
Documentation Requirements You Cannot Ignore
Even with the perfect codes, a payer can deny your claim if your documentation is weak. Here is exactly what your medical record must include for every Enhertu visit.
- Patient’s weight and body surface area (BSA) – Because dosing is weight-based.
- Calculated dose in mg – Show your math.
- Actual dose administered – This should match the J9359 units.
- Start and stop time of the infusion – Essential for 96413 and +96415.
- Lot number and expiration date – For the drug itself, especially for waste billing.
- Pre-medications given – Include route, times, and dosages.
- Infusion site and any reactions – Monitor for infusion-related issues.
If any of these are missing, consider the claim at risk. A simple audit will find the gaps.
Billing for Enhertu in Non-Oncology Settings
Enhertu is primarily given in oncology clinics and hospital infusion centers. However, some patients receive it in home infusion or skilled nursing facilities.
Can you bill 96413 in a skilled nursing facility (SNF)? Yes. But SNFs bill under Medicare Part A (if the patient is in a covered stay) or Part B (for outpatient services). In a Part A stay, the drug and administration are bundled into the Prospective Payment System (PPS) rate unless the patient has a “non-covered stay” or you are billing a Part B SNF service.
For home infusion, Enhertu is rarely given due to the risk of infusion reactions. But if it is, you would use the same codes. However, home health agencies often use G-codes for therapy services. That is a complex area, so always check with your home health intermediary.
Private Payer Variations: Not Everyone Follows Medicare
Medicare’s rules are clear. But what about Blue Cross, UnitedHealthcare, Aetna, or Cigna?
Most commercial plans follow the same CPT coding structure. They accept 96413 and J9359. However, there are differences.
- Prior authorization: Almost all private payers require prior auth for Enhertu. The drug is extremely expensive. Without an approved prior authorization, your claim will deny regardless of the codes.
- Step therapy: Some plans require patients to try other HER2-targeted therapies first (like Herceptin or Kadcyla) before approving Enhertu. Document this carefully.
- Site of care restrictions: Many private plans push patients to lower-cost sites. They may require the infusion to occur in a physician’s office rather than a hospital outpatient department. If you bill for a hospital outpatient service but the plan mandates a lower site, the claim may pay at the lower rate or deny.
Your best tool is the payer’s medical policy. Search for “Enhertu medical policy” on the payer’s provider portal. That document will list the exact CPT codes, ICD-10 codes, and any special billing instructions.
FAQs About Enhertu CPT Code
Q1: What is the primary CPT code for Enhertu administration?
A: The primary code is 96413 for the first hour of IV infusion. For each additional hour, add +96415.
Q2: Can I bill a separate code for IV push pre-meds before Enhertu?
A: Generally, no. If pre-meds are given immediately before the Enhertu infusion with no break, they are bundled into the chemotherapy administration code (96413). Separate billing is only allowed if there is a distinct, clinically separate service.
Q3: What HCPCS code do I use for Enhertu drug itself?
A: Use J9359. Bill one unit for each milligram administered. For example, a 300 mg dose is J9359 x 300 units.
Q4: How do I bill for Enhertu that is wasted from a vial?
A: Add modifier -JW to the J9359 line for the wasted amount. Document the exact amount wasted in the medical record.
Q5: Is there a specific diagnosis code required for Enhertu?
A: Yes. You need the principal cancer diagnosis (e.g., breast cancer, C50.xxx) and a secondary code Z51.11 (encounter for antineoplastic chemotherapy). The primary cancer code must match an FDA-approved indication.
Q6: What is the minimum infusion time to bill 96413?
A: Most payers require at least 15 minutes. Some require 16 minutes. Always check your local payer policy. If the infusion is shorter than that, you might bill 96374 (therapeutic push) but that is rarely appropriate for Enhertu.
Q7: Do I need a modifier when billing 96413 with +96415?
A: No special modifier is needed for the time add-on. The +96415 code itself indicates it is an add-on service. Just ensure your total time documentation supports the units billed.
Q8: Can a nurse bill 96413 independently?
A: No. The facility or practice bills the service. The nurse does not submit a personal claim. The provider (physician or advanced practice provider) orders the service, and the facility/practice bills under their NPI.
Additional Resource
For the most up-to-date coding and payment information, visit the CMS HCPCS quarterly update page and the official Enhertu provider portal (managed by AstraZeneca). Their reimbursement hotline offers free coding support for practices. Always download the latest coding guide from the manufacturer.
🔗 Link: Enhertu HCPCS & Coding Resources – AstraZeneca (example, always verify current URL)
Important Note for Readers
Coding rules change. Payer policies vary by state and plan. This guide reflects standard practices as of April 27, 2026. However, local coverage determinations (LCDs) and commercial plan medical policies can differ. Before submitting any claim, verify the codes with your specific payer. Do not rely solely on this article for claim submission. When in doubt, contact your payer’s provider line or consult a certified professional coder.
Conclusion
Billing for Enhertu does not have to be a headache. Remember three key things. First, use 96413 for the first hour of infusion and +96415 for each additional hour. Second, report the drug itself with J9359, billing one unit per milligram. Third, document everything thoroughly, especially infusion times and any drug waste using modifier -JW. Follow these guidelines, and your claims will have a much higher chance of clean, timely payment.
